If you have MS, smoke dope if you wish but consider that dope alone will not do for you what BCG alone will do for you or dope combined with BCG. The use of diseases to advocate the usefulness of smoking dope must be tempered by the realization that even Italian Andrew Cuomo must consider the merits of his countryman Ristori and wonder whether smoking dope when you have MS may be enhanced by smoking dope and shooting BCG, which is also safe, cheap and effective, everything that is undesireable in the American healthcare system.
Smoke Dope, Shoot BCG , or do neither but please do not contribute to
Adwww.nationalmssociety.org/
Learn about MS programs, services, and information we offer.
stand in the way of those in NY with autoimmune diseases who wish to smoke dope and/or shoot BCG or see that others may do so.
If you have an autoimmune disease other than MS, by all mean smoke dope and yet not be blind to the Red Sox medicine and art found in Boston and published by Red Sox Fan Dr. Denise L Faustman. See eg faustmanlab.org and pubmed.org faustman dl. There is nothing wrong with smoking dope? There is something wrong when BCG used all over the world is not available to New Yorkers. BCG has been used on pregnant women in Europe. Ask Delthia Ricks of Newsday for the references which will be added to this post shortly.
Tom Libous might profit from searching pubmed.org metformin cancer
and pubmed.org aspirin cancer
He might even wonder why no one has suggested to him combining metformin and aspirin with or without smoking dope
>>> Rigshospitalet <news@meltwaterpress.com> 9/3/2012 9:27 AM >>>
Press release |
3rd of September 2012 |
Tuberculosis vaccine - a new remedy for allergies and asthma in children?
M Can a vaccine against tuberculosis help combat asthma
and eczema in Danish children early in life? This will now be examined
in a comprehensive Danish research study.
From September 2012, thousands of Danish pregnant women will receive an
invitation to allow their newborns to take part in a sensational trial.
The tuberculosis vaccine was removed from the vaccine program in Denmark
during the 1980s, however new research indicates that the vaccine can
improve the health of children.
Research carried out in developing countries shows that the health of
infants who have been given the tuberculosis vaccine (BCG/Calmette) at
birth is improved and the babies have a better survival rate than those
who have not been given the vaccine. The vaccine
also seems to have a preventive effect against asthma and atopic
dermatitis.
Results are so striking that they cannot be explained by the fact that
the children did not catch tuberculosis. Therefore, researchers assess
the vaccine to have a general positive effect on the immune system,
which means that children are less sick, and have
less atopic dermatitis, asthma and allergies.
Whether this positive effect also can benefit Danish children will now
be examined in a large Danish research project headed by Lone Graff
Stensballe, Paediatrician from the Department of Paediatrics and
Adolescent Medicine at Rigshospitalet.
The research project will run for three years, starting in September
2012, where 4,300 infants and their parents will be followed through
interviews, examinations, and, for 300 of the children, blood tests as
well. The project will comprise five PhD courses
and a research collaboration with obstetricians, paediatricians,
midwives, nurses and laboratory technicians from the three hospitals
taking part in the project.
“We are very excited about this unique opportunity to improve the health
of Danish children early in life,” says Lone Graff Stensballe.
“Unfortunately, we have seen large increases in admissions, consumption
of medicines, asthma, eczema and allergies among
Danish children. We hope to curb these increases with the new research
project.”
The research project will be carried out at Rigshospitalet in
collaboration with Hvidovre Hospital, Kolding Sygehus Lillebælt and the
new Centre for Vitamins and Vaccines at SSI (Statens Serum Institut).
For further information and interviews, please contact:
Lone Graff Stensballe
Head of Research
Paediatrician, Department of Paediatrics and Adolescent Medicine, Rigshospitalet, Denmark
Telephone: +45 6022 8092 E-mail:
lone.graff.stensballe@rh.regionh.dk
|
| Rigshospitalet - a part of Copenhagen University Hospital |
 |
|
Rigshospitalet – a part of Copenhagen University Hospital – is
Denmark'sleading hospital for patients needing highly specialized
treatment. Rigshospitalet serves all of Denmark, Greenland and the Faroe
Islands within almost all specialties and sub-specialties
of medicine and surgery.
|
Afmelding: Ønsker du ikke længere at få tilsendt e-mails fra Rigshospitalet via Meltwater Press, venligst klik:
[her]. Afmelding kan tage op til 2 arbejdsdage.
Hvis du ønsker at kontakte Meltwater Press, kan du kontakte Meltwater Press på:
Meltwater Group Christian IX's Gade 10, 2. 1111 København K 
--------------------------------------------------------
The information transmitted in this email and any of its attachments is
intended only for the person or entity to which it is addressed and may
contain information concerning Cablevision and/or its affiliates and
subsidiaries that is proprietary, privileged,
confidential and/or subject to copyright. Any review, retransmission,
dissemination or other use of, or taking of any action in reliance upon,
this information by persons or entities other than the intended
recipient(s) is prohibited and may be unlawful. If
you received this in error, please contact the sender immediately and
delete and destroy the communication and all of the attachments you have
received and all copies thereof.
I am available to demonstrate on You Tube the effectiveness of BCG on plaque psoriasis. I am also a Type 1 diabetic. I'd rather shoot BCG than smoke dope, but to each his own.
NY Senate approves medical marijuana, bill goes to Cuomo for signature
Sen. Diane Savino, D-Staten Island, listens to a speaker
during a news conference announcing an agreement on legislation
legalizing medical marijuana in New York in the Red Room at the Capitol
on Thursday. The bill passed the Senate this afternoon and the bill will
be sent to Gov. Andrew Cuomo.
(Mike Groll)
ALBANY, N.Y. - Medical marijuana could be available in smokeless forms in about 18
months, after New York senators sent legislation to Gov. Andrew Cuomo this
afternoon.
The Senate approved
the legislation
49-10 after more than two and a half hours of debate. Advocates for the
bill cheered and hugged afterward and cried out "Thank you" from the
Senate gallery.
The legislation
had been agreed to by legislative leaders and Gov. Andrew Cuomo; the governor is expected to sign the bill.
Today's votes crossed party lines and personal illnesses and past careers in law enforcement and the military.
Sen. Tom Libous, R-Binghamton, whose prostate cancer has spread to
his lungs, spoke movingly of pain and chemotherapy before saying he
would vote no. Sen. Patrick Gallivan, R-Elma, a former New York State
trooper, voted yes.
Sen. William Larkin, R-Troy, a military veteran and senator for 36
years, challenged
his colleagues to consider what they would do to help ease the pain of a
suffering child. It was his vote a few weeks ago that moved the bill out
of the Senate's Health Committee, a first for the state Senate. "Lead
or get the hell out of the way," Larkin declared before voting yes.
The outcome of today's vote was expected. But it came after a two-decade fight by
Assemblyman Richard Gottfried, D-Manhattan, to allow New Yorkers access to
marijuana as a treatment for conditions such as cancer, epilepsy and neuropathies.
DeFrancisco
opened the debate with questions about how the program would work. He asked how
doctors would know how much marijuana to prescribe, how much the drug would
cost, how state officials are sure that marijuana can curb pain, nausea and
other symptoms.
The
bill's sponsor, Sen. Diane Savino, D-Staten Island, said it's up to the state's
health commissioner to write rules and regulations regarding the program,
including standards for dosages and costs. She said the costs should be on par
with illegal sales of marijuana, so that qualifying patients won't be tempted to
save money and buy the drug through criminal channels.
Savino also acknowledged the criticisms that not enough clinical
tests exist regarding the medical uses of marijuana. "The FDA doesn't
always provide us the comfort that we need," she said.
DeFrancisco congratulated Savino and advocates for the legislation
before voting no. "They worked very, very hard," DeFrancisco said,
adding that the bill's name - the Compassionate Care Act - made it hard
for some to vote no. "How can you vote against compassionate care?"
Sen.
David Valesky, D-Oneida, supported the bill.
Other
Central New York senators opposed it, including Sens. John DeFrancisco,
R-Syracuse; Joseph Griffo, R-Rome; Michael Nozzolio, R-Fayette; Patty Ritchie,
R-Oswegatchie; and James Seward, R-Milford.
The
New York State Assembly passed the legislation 113-17 shortly before 3 a.m.
today. All Central New York Assembly members from both parties supported the
legislation.
It
was unclear immediately after the vote when Gov. Andrew Cuomo would sign the
bill. The program will take effect 18 months after Cuomo signs it, or later,
according to the legislation.
Even
after Cuomo signs the bill, it will still be illegal for any patient to smoke marijuana
for health reasons until the program is established.
Libous
voted no, even though he admitted he's said he would consider using marijuana
to help with the aftermath of chemotherapy treatments should the drug become
illegal. He said he wanted more scientific evidence that the drug is of medical
benefit. He also said he didn't want people to get the impression that
marijuana might be a cure-all for people suffering pain or seizures.
"I
also know that this isn't a cure," Libous said. "I don't want to create a false
hope. This isn't going to cure anybody."
Savino said after the vote she didn't know when Cuomo might sign the bill. "Soon, we hope," she said.
Contact Teri Weaver at tweaver@syracuse.com, 315-470-2274 or on Twitter at @TeriKWeaver.
Immunobiology
Laboratory Denise
Faustman, MD, PhD
Massachusetts
General Hospital
East Director, Immunobiology Laboratory
Building 149, Thirteenth Street, Room 3601 Associate Professor of Medicine
Charlestown,
Massachusetts
02129 Harvard Medical School
Tel: 617-726-4084
Fax: 617-726-4095
June 20, 2014
Dear Friends,
As we head into summer, we wanted to get you up to date on all of the exciting developments both
inside and outside of the laboratory and the clinic.
It was a busy spring here in Boston. The
book
based on our BCG conference (held in London this
past October)
was published
last month, and we are excited to speak with a growing number of
researchers who are interested in trials using BCG to reverse or prevent autoimmunity.
And what about our Phase II BCG trial? While you are (hopefully!) at the beach, we will be putting
the final touches on the clinical trial design. We are hopeful that the first patients will be receiving
BCG this year. We have raised over $18 million now for this trial, but need another $7 million to
complete it.
For our European friends, we will be presenting at the
EASD meeting in Vienna this September.
Stay tuned and, of course, thank you for all of your support. You can always find more information
Sincerely,
Denise L. Faustman
The information in this e-mail is intended only for the person to whom it is
addressed. If you believe this e-mail was sent to you in error and the e-mail
contains patient information, please contact the Partners Compliance HelpLine at
http://www.partners.org/complianceline . If the e-mail was sent to you in error
but does not contain patient information, please contact the sender and properly
dispose of the e-mail.
Mangano on the issues
Blog: Spin Cycle
Mangano through the years
Fee hikes: Details
Search Nassau salaries
Data: Nassau pay raises
Nassau 2012 payroll
